Centre for Vision Research, Department of Ophthalmology, University of Sydney, Sydney, Australia2Westmead Millennium Institute, Westmead Hospital, Westmead, Australia.
JAMA Ophthalmol. 2015 Jun;133(6):698-705. doi: 10.1001/jamaophthalmol.2015.0498.
The natural course and prognosis of medium drusen and risk factors associated with the incidence and progression of this lesion type in age-related macular degeneration (AMD) are not well understood.
To assess the 15-year incidence and progression of medium drusen and associated risk factors.
DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort in the Blue Mountains region, west of Sydney, Australia. Included in the study were 3654 participants 49 years or older who attended baseline examinations of the Blue Mountains Eye Study (1992-1994), and 75.8%, 76.7%, and 56.1% of survivors who attended the 5-year, 10-year, and 15-year follow-up examinations, respectively.
Color retinal fundus photographs were obtained at each examination. The incidence and progression of medium drusen (maximum diameter, 63 to <125 µm) were assessed using Kaplan-Meier product-limit survival methods, controlling for competing risk of death. Factors associated with a 15-year incidence of medium drusen were assessed using discrete logistic regression models after adjusting for age, sex, smoking status, serum lipid levels, systemic and dietary factors, and CFH rs1061170 and ARMS2 rs10490924 polymorphisms. Associations between lesion characteristics and the progression to late AMD were assessed using generalized estimating equation models and eye-specific data.
Among 1317 participants at risk, the 15-year cumulative incidence of medium drusen was 13.9% (n = 281). Increasing age (per decade older) (odds ratio [OR], 1.4; 95% CI, 1.2-1.8) and the presence of at least 3 risk alleles of the CFH rs1061170 or ARMS2 rs10490924 genes (OR, 2.1; 95% CI, 1.1-4.1) were associated with a higher incidence. There was no association between past smoking (OR, 0.8; 95% CI, 0.6-1.1) or current smoking (OR, 0.6; 95% CI, 0.4-1.1) and the development of medium drusen. The progression rate to late AMD in eyes with both medium drusen and retinal pigmentary abnormalities was 4-fold higher than that in eyes with medium drusen alone. Larger total area and central location of medium drusen were associated with a greater likelihood of the progression to worse stages of AMD.
Older age and the presence of CFH and ARMS2 risk alleles are 2 main risk factors associated with the development of medium drusen. The copresence of medium drusen plus retinal pigment epithelium abnormalities signals a greater risk of the progression to late AMD than the presence of medium drusen alone.
中玻璃膜疣的自然病程和预后以及与年龄相关性黄斑变性(AMD)中这种病变类型的发生和进展相关的危险因素尚不清楚。
评估中玻璃膜疣的 15 年发生率和进展情况以及相关的危险因素。
设计、地点和参与者:这是一项在澳大利亚悉尼以西的蓝山地区进行的基于人群的队列研究。研究纳入了在蓝山眼病研究(1992-1994 年)基线检查时年龄在 49 岁及以上的 3654 名参与者,分别有 75.8%、76.7%和 56.1%的幸存者参加了 5 年、10 年和 15 年的随访检查。
每次检查均获取彩色视网膜眼底照片。使用 Kaplan-Meier 乘积限生存法评估中玻璃膜疣(最大直径为 63 至<125 µm)的发生率和进展情况,同时控制死亡的竞争风险。使用离散逻辑回归模型评估与中玻璃膜疣 15 年发生率相关的因素,这些因素在调整年龄、性别、吸烟状况、血清脂质水平、全身和饮食因素以及 CFH rs1061170 和 ARMS2 rs10490924 多态性后进行分析。使用广义估计方程模型和眼特异性数据评估病变特征与晚期 AMD 进展之间的相关性。
在 1317 名有风险的参与者中,15 年累积中玻璃膜疣发生率为 13.9%(n=281)。年龄每增加 10 岁(OR,1.4;95%CI,1.2-1.8)和 CFH rs1061170 或 ARMS2 rs10490924 基因至少存在 3 个风险等位基因(OR,2.1;95%CI,1.1-4.1)与更高的发生率相关。过去吸烟(OR,0.8;95%CI,0.6-1.1)或当前吸烟(OR,0.6;95%CI,0.4-1.1)与中玻璃膜疣的发生无关。同时存在中玻璃膜疣和视网膜色素异常的眼睛进展为晚期 AMD 的速度是仅有中玻璃膜疣的眼睛的 4 倍。中玻璃膜疣的总面积较大和中央位置与更有可能进展为 AMD 更严重阶段相关。
年龄较大和 CFH 和 ARMS2 风险等位基因的存在是与中玻璃膜疣发生相关的 2 个主要危险因素。同时存在中玻璃膜疣和视网膜色素上皮异常提示进展为晚期 AMD 的风险大于仅有中玻璃膜疣的情况。